Literature DB >> 16098722

Humoral theory of transplantation: further evidence.

Paul I Terasaki1, Junchao Cai.   

Abstract

In the two and a half years following our initial paper on the humoral theory of transplantation, many publications have emerged in support of the hypothesis, with no studies in opposition. It is accepted that the role of antibodies is incontrovertible in hyperacute rejection, although what fraction of acute rejection is humoral remains to be determined. A recent large-scale prospective trial showing that transplant patients with antibodies have twice the failure rate as those without antibodies suggests that chronic rejection is also caused by antibodies. Together with serum creatinine, HLA antibodies are, therefore, the best predictor of graft function in kidney patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098722     DOI: 10.1016/j.coi.2005.07.018

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  36 in total

1.  Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses.

Authors:  Fabrice Porcheray; Julie DeVito; Beow Y Yeap; Lijuan Xue; Ian Dargon; Rosemary Paine; Timothy C Girouard; Susan L Saidman; Robert B Colvin; Waichi Wong; Emmanuel Zorn
Journal:  Transplantation       Date:  2010-05-27       Impact factor: 4.939

Review 2.  Immunogenicity and allogenicity: a challenge of stem cell therapy.

Authors:  Dominique Charron; Caroline Suberbielle-Boissel; Reem Al-Daccak
Journal:  J Cardiovasc Transl Res       Date:  2008-09-26       Impact factor: 4.132

3.  HLA Genotyping and Antibody Characterization Using the Luminex™ Multiplex Technology.

Authors:  Falko Markus Heinemann
Journal:  Transfus Med Hemother       Date:  2009-07-21       Impact factor: 3.747

4.  Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells.

Authors:  Phillip H Horne; Jason M Zimmerer; Mason G Fisher; Keri E Lunsford; Gyongyi Nadasdy; Tibor Nadasdy; Nico van Rooijen; Ginny L Bumgardner
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

Review 5.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

6.  Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection.

Authors:  Qiquan Sun; Dongrui Cheng; Mingchao Zhang; Qunpeng He; Zhaohong Chen; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

7.  Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus.

Authors:  Y-P Jin; N M Valenzuela; M E Ziegler; E Rozengurt; E F Reed
Journal:  Am J Transplant       Date:  2014-03-01       Impact factor: 8.086

8.  Protein extraction and 2-DE of water- and lipid-soluble proteins from bovine pericardium, a low-cellularity tissue.

Authors:  Leigh G Griffiths; Leila Choe; Kelvin H Lee; Kenneth F Reardon; E Christopher Orton
Journal:  Electrophoresis       Date:  2008-11       Impact factor: 3.535

9.  The clinical impact of humoral immunity in pediatric renal transplantation.

Authors:  Abanti Chaudhuri; Mikki Ozawa; Matthew J Everly; Robert Ettenger; Vikas Dharnidharka; Mark Benfield; Robert Mathias; Anthony Portale; Ruth McDonald; William Harmon; David Kershaw; V Matti Vehaskari; Elaine Kamil; H Jorge Baluarte; Bradley Warady; Li Li; Tara K Sigdel; Szu-chuan Hsieh; Hong Dai; Maarten Naesens; Janie Waskerwitz; Oscar Salvatierra; Paul I Terasaki; Minnie M Sarwal
Journal:  J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 10.121

Review 10.  Graft failure after allogeneic hematopoietic cell transplantation.

Authors:  Jonas Mattsson; Olle Ringdén; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.